Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer | Zendy

Sanjit Kumar Agrawal | Zendy; Izideen Hashlamoun | Zendy; Banira Karki | Zendy; Abhishek Sharma | Zendy; Indu Arun | Zendy; Rosina Ahmed | Zendy

Open Access

Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer

Author(s) -

Sanjit Kumar Agrawal,

Izideen Hashlamoun,

Banira Karki,

Abhishek Sharma,

Indu Arun,

Rosina Ahmed

Publication year - 2020

Publication title -

jco global oncology

Language(s) - English

Resource type - Journals

ISSN - 2687-8941

DOI - 10.1200/go.20.00165

Subject(s) - indocyanine green , medicine , sentinel lymph node , breast cancer , methylene blue , biopsy , lymph , nuclear medicine , gold standard (test) , cancer , radiology , surgery , pathology , chemistry , biochemistry , photocatalysis , catalysis

Sentinel lymph node biopsy (SLNB) by dual-dye method (radioisotope plus blue) is the gold standard for axillary staging in patients with breast cancer, but in developing countries, logistic issues and financial constraint play a vital role. Recently, indocyanine green (ICG) has emerged as an alternative to radioisotope (technetium-99 [Tc-99]) for SLNB in breast cancer. This study compared the diagnostic performance of Tc-99 plus methylene blue (MB) dye versus ICG + MB dye SLNB.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research